Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei

A G Taranukhin1, E Y Taranukhina, P Saransaari

  • 1Brain Research Center, University of Tampere Medical School, Tampere, Finland. Andrey.Taranukhin@uta.fi

Amino Acids
|February 14, 2007
PubMed

Insights

Taurine protects brain cells from apoptosis caused by ischemia. This study shows taurine significantly reduces the expression of key apoptosis-inducing enzymes, caspase-8 and caspase-9, in hypothalamic nuclei.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Taurine is a sulfur-containing amino acid prevalent in the nervous system.
  • Taurine is known to protect cells from ischemia-induced apoptosis, but the exact mechanisms are unclear.
  • Apoptosis can be triggered by receptor-mediated or mitochondrial pathways.

Purpose of the Study:

  • To investigate taurine's effects on receptor-mediated and mitochondrial apoptosis pathways.
  • To examine taurine's impact on caspase-8 and caspase-9 expression in hypothalamic nuclei under ischemic conditions.

Main Methods:

  • Brain slices from rat supraoptic (SON) and paraventricular (PVN) nuclei were subjected to simulated ischemia (oxygen-glucose deprivation).
  • Slices were treated with or without 20 mM taurine during and after ischemia.
  • Apoptosis was assessed by immunostaining for caspase-8 and caspase-9 in post-ischemic brain slices.

Main Results:

  • Ischemia significantly increased caspase-8 and caspase-9 expression and immunoreactive cell counts in SON and PVN.
  • Taurine treatment markedly reduced ischemia-induced caspase-8 and caspase-9 immunoreactivity in both nuclei.
  • Taurine demonstrated a protective effect against apoptosis in the studied hypothalamic regions.

Conclusions:

  • Taurine effectively reduces the expression of caspase-8 and caspase-9, critical mediators of apoptosis.
  • These findings elucidate a key mechanism by which taurine confers neuroprotection against ischemic injury.
  • Taurine shows promise as a therapeutic agent for conditions involving hypothalamic damage due to ischemia.